Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer

PURPOSE: RTOG 0617 compared standard-dose (SD; 60 Gy) versus high-dose (HD; 74 Gy) radiation with concurrent chemotherapy and determined the efficacy of cetuximab for stage III non–small-cell lung cancer (NSCLC). METHODS: The study used a 2 × 2 factorial design with radiation dose as 1 factor and ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Bradley, Jeffrey D., Hu, Chen, Komaki, Ritsuko R., Masters, Gregory A., Blumenschein, George R., Schild, Steven E., Bogart, Jeffrey A., Forster, Kenneth M., Magliocco, Anthony M., Kavadi, Vivek S., Narayan, Samir, Iyengar, Puneeth, Robinson, Clifford G., Wynn, Raymond B., Koprowski, Christopher D., Olson, Michael R., Meng, Joanne, Paulus, Rebecca, Curran, Walter J., Choy, Hak
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048161/
https://ncbi.nlm.nih.gov/pubmed/31841363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados